Treatment plans optimization for contrast-enhanced synchrotron stereotactic radiotherapy

Medical Physics

Volumn 37, Issue 6, 2010, Pages 2445-2456

  Edouard, M ^a,b,c   Broggio, D ^d   Prezado, Y ^c   Estve F ^a,b,c,e   Elleaume, H ^a,b,c,e   Adam, J F ^a,b,c,e  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Contrast agents; Monte Carlo dosimetry; Stereotactic radiotherapy; Synchrotron radiation

Indexed keywords

BRAIN; DOSIMETRY; GEOMETRY; IODINE; IRRADIATION; PHANTOMS; RADIOTHERAPY; SYNCHROTRON RADIATION; SYNCHROTRONS; TUMORS; X RAY TUBES;

CONTRAST AGENT; CONTRAST-ENHANCED RADIOTHERAPIES; EUROPEAN SYNCHROTRON RADIATION FACILITIES; IODINATED CONTRAST AGENTS; MONTE CARLO DOSIMETRY; STEREOTACTIC IRRADIATIONS; STEREOTACTIC RADIOTHERAPY; SYNCHROTRON STEREOTACTIC RADIOTHERAPIES;

X RAYS;

EID: 77953531903     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3327455     Document Type: Article

References (47)

1. R. Stupp, M. E. Hegi, M. R. Gilbert, and A. Chakravarti, " Chemoradiotherapy in malignant glioma: Standard of care and future directions.," J. Clin. Oncol. JCONDN 0732-183X 25, 4127-4136 (2007). 10.1200/JCO.2007.11.8554 (Pubitemid 47492957)
2. P. Y. Wen and S. Kesari, " Malignant gliomas in adults.," N. Engl. J. Med. NEJMAG 0028-4793 359, 492-507 (2008). 10.1056/NEJMra0708126
3. A. R. Kagan, H. A. Gilbert, H. Nussbaum, P. Chan, J. Wagner, and K. Fuchs, " Success of treatment of brain metastasis with radiation therapy.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 2, 74-75 (1977). 10.1016/0360-3016(77)90375-3
4. W. Roa, " Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial.," J. Clin. Oncol. JCONDN 0732-183X 22, 1583-1588 (2004). 10.1200/JCO.2004.06.082 (Pubitemid 41079795)
5. J. F. Adam, M. C. Biston, J. Rousseau, C. Boudou, A. M. Charvet, J. Balosso, F. Esteve, and H. Elleaume, " Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment.," Phys. Med. 24, 92-97 (2008). 10.1016/j.ejmp.2008.02.003 1120-1797
6. H. H. Callisen, A. Norman, and F. H. Adams, " Absorbed dose in the presence of contrast agents during pediatric cardiac catheterization.," Med. Phys. MPHYA6 0094-2405 6, 504-509 (1979). 10.1118/1.594613 (Pubitemid 10185593)
7. R. G. Fairchild and V. P. Bond, " Photon-activation therapy.," Strahlentherapie STRAAA 0039-2073 160, 758-763 (1984).
8. R. Santos Mello, H. Callisen, J. Winter, A. R. Kagan, and A. Norman, " Radiation dose enhancement in tumors with iodine.," Med. Phys. MPHYA6 0094-2405 10, 75-78 (1983). 10.1118/1.595378 (Pubitemid 13164049)
9. K. S. Iwamoto, A. Norman, A. R. Kagan, M. Wollin, A. Olch, J. Bellotti, M. Ingram, and R. G. Skillen, " The CT scanner as a therapy machine.," Radiother. Oncol. RAONDT 0167-8140 19, 337-343 (1990). 10.1016/0167-8140(90) 90034-T
10. S. T. Cochran, K. Iwamoto, J. Winter, and A. Norman, " Radiation dose enhancement with iodine in brain tumors.," Med. Phys. MPHYA6 0094-2405 13, 615 (1986).
11. K. S. Iwamoto, S. T. Cochran, J. Winter, E. Holburt, R. T. Higashida, and A. Norman, " Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors.," Radiother. Oncol. RAONDT 0167-8140 8, 161-170 (1987). 10.1016/S0167-8140(87)80170-6
12. K. S. Iwamoto, A. Norman, D. B. Freshwater, M. Ingram, and R. G. Skillen, " Diagnosis and treatment of spontaneous canine brain-tumors with a CT scanner.," Radiother. Oncol. RAONDT 0167-8140 26, 76-78 (1993). 10.1016/0167-8140(93)90030-C
13. A. Norman, M. Ingram, R. G. Skillen, D. B. Freshwater, K. S. Iwamoto, and T. Solberg, " X-ray phototherapy for canine brain masses.," Radiat. Oncol. Invest. ROINEU 1065-7541 5, 8-14 (1997). 10.1002/(SICI)1520-6823(1997)5: 1<8::AID-ROI2>3.0.CO;2-1 (Pubitemid 27258351)
14. J. H. Rose, A. Norman, M. Ingram, C. Aoki, T. Solberg, and A. Mesa, " First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx).," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 45, 1127-1132 (1999). 10.1016/S0360-3016(99)00347-8
15. T. D. Solberg, K. S. Iwamoto, and A. Norman, " Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours.," Phys. Med. Biol. PHMBA7 0031-9155 37, 439-443 (1992). 10.1088/0031-9155/37/2/010
16. A. V. Mesa, A. Norman, T. D. Solberg, J. J. Demarco, and J. B. Smathers, " Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents.," Phys. Med. Biol. PHMBA7 0031-9155 44, 1955-1968 (1999). 10.1088/0031-9155/44/8/308 (Pubitemid 29387604)
17. J. F. Adam, A. Joubert, M. C. Biston, A. M. Charvet, M. Peoc'h, J. F. Le Bas, J. Balosso, F. Esteve, and H. Elleaume, " Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 64, 603-611 (2006). 10.1016/j.ijrobp.2005.09.004
18. J. F. Adam, M. C. Biston, A. Joubert, A. M. Charvet, J. F. Le Bas, F. Esteve, and H. Elleaume, " Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: Quantitative iodine biodistribution studies and associated dosimetry.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 61, 1173-1182 (2005). 10.1016/j.ijrobp.2004.12.026
19. J. F. Adam, H. Elleaume, A. Joubert, M. C. Biston, A. M. Charvet, J. Balosso, J. F. Le Bas, and F. Esteve, " Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: First trial on rats bearing F98 gliomas.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 57, 1413-1426 (2003). 10.1016/j.ijrobp.2003.07.007
20. M. C. Biston, A. Joubert, J. F. Adam, H. Elleaume, S. Bohic, A. M. Charvet, F. Esteve, N. Foray, and J. Balosso, " Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays.," Cancer Res. CNREA8 0008-5472 64, 2317-2323 (2004). 10.1158/0008-5472.CAN-03-3600 (Pubitemid 38523880)
21. C. Boudou, J. Balosso, F. Esteve, and H. Elleaume, " Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours.," Phys. Med. Biol. PHMBA7 0031-9155 50, 4841-4851 (2005). 10.1088/0031-9155/50/20/ 007 (Pubitemid 41417007)
22. C. Boudou, I. Tropres, J. Rousseau, L. Lamalle, J. F. Adam, F. Esteve, and H. Elleaume, " Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements.," Phys. Med. Biol. PHMBA7 0031-9155 52, 4881-4892 (2007). 10.1088/0031-9155/52/16/011 (Pubitemid 47232293)
23. Y. Prezado, G. Fois, M. Edouard, C. Nemoz, M. Renier, H. Requardt, F. Esteve, J. F. Adam, H. Elleaume, and A. Bravin, " Biological equivalent dose studies for dose escalation in the stereotactic synchrotron radiation therapy clinical trials.," Med. Phys. MPHYA6 0094-2405 36, 725-733 (2009). 10.1118/1.3070538
24. L. S. Waters, G. W. McKinney, J. W. Durkee, M. L. Fensin, J. S. Hendricks, M. R. James, R. C. Johns, and D. B. Pelowitz, " The MCNPX Monte Carlo radiation transport code.," presented at the Proceedings of the Hadronic Shower Simulation Workshop, Batavia, IL, 2006 (unpublished).
25. https://mcnpx.lanl.gov/
26. L. G. Bouchet, W. E. Bolch, D. A. Weber, H. L. Atkins, and J. W. Poston, " A revised dosimetric model of the adult head and brain.," J. Nucl. Med. JNMEAQ 0161-5505 37, 1226-1236 (1996).
27. R. S. Snyder, M. R. Ford, and G. G. Warner, " Estimate of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous plantom.," MIRD Pamphlet No. 5 (Society of Nuclear Medicine, New York, NY, 1978).
28. O. K. Harling, K. A. Roberts, D. J. Moulin, and R. D. Rogus, " Head phantoms for neutron-capture therapy.," Med. Phys. MPHYA6 0094-2405 22, 579-583 (1995). 10.1118/1.597545
29. ICRU, " Photon, electron, proton and neutron interaction data for body tissues.," ICRU Report No. 46 (ICRU, Bethesda, MD, 1992).
30. F. Verhaegen, A. E. Nahum, S. Van De Putte, and Y. Namito, " Monte Carlo modeling of radiotherapy kV x-ray units.," Phys. Med. Biol. PHMBA7 0031-9155 44, 1767-1789 (1999). 10.1088/0031-9155/44/7/315 (Pubitemid 29336339)
31. F. Verhaegen, B. Reniers, F. Deblois, S. Devic, J. Seuntjens, and D. Hristov, " Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays.," Phys. Med. Biol. PHMBA7 0031-9155 50, 3555-3569 (2005). 10.1088/0031-9155/50/15/005 (Pubitemid 41019096)
32. S. Chiavassa, I. Aubineau-Laniece, A. Bitar, A. Lisbona, J. Barbet, D. Franck, J. R. Jourdain, and M. Bardies, " Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code.," Phys. Med. Biol. PHMBA7 0031-9155 51, 601-616 (2006). 10.1088/0031-9155/51/3/009 (Pubitemid 43139107)
33. S. Chiavassa, M. Bardies, F. Guiraud-Vitaux, D. Bruel, J. R. Jourdain, D. Franck, and I. Aubineau-Laniece, " OEDIPE: A personalized dosimetric tool associating voxel-based models with MCNPX.," Cancer Biother. Radiopharm. CBRAFJ 1084-9785 20, 325-332 (2005). 10.1089/cbr.2005.20.325 (Pubitemid 41003837)
34. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, " Tolerance of normal tissue to therapeutic irradiation.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 21, 109-122 (1991). 10.1016/0360-3016(91)90171-Y
35. J. Rousseau, J. F. Adam, P. Deman, T. D. Wu, J. L. Guerquin-Kern, B. Gouget, R. F. Barth, F. Esteve, and H. Elleaume, " Intracerebral delivery of 5-iodo- 2′ -deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma.," J. Synchrotron Radiat. JSYRES 0909-0495 16, 573-581 (2009). 10.1107/S0909049509016987
36. J. Rousseau, C. Boudou, R. F. Barth, J. Balosso, F. Esteve, and H. Elleaume, " Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation.," Clin. Cancer Res. ZZZZZZ 1078-0432 13, 5195-5201 (2007). 10.1158/1078-0432.CCR-07-1002 (Pubitemid 47502089)
37. G. Le Duc, S. Corde, A. M. Charvet, H. I. N. Elleaume, N. Farion, J. F. Le Bas, and F. Esteve, " In vivo measurement of gadolinium concentration in a rat glioma model by monochromatic quantitative computed tomography-Comparison between gadopentetate dimeglumine and gadobutrol.," Invest. Radiol. INVRAV 0020-9996 39, 385-393 (2004). 10.1097/01.rli.0000124250.61768.c0 (Pubitemid 38802813)
38. C. Alric, R. Serduc, C. Mandon, J. Taleb, G. Le Duc, A. Le Meur-Herland, C. Billotey, P. Perriat, S. Roux, and O. Tillement, " Gold nanoparticles designed for combining dual modality imaging and radiotherapy.," Gold Bull. GOBUFW 1027-8591 41, 90-97 (2008).
39. C. Alric, J. Taleb, G. Le Duc, C. Mandon, C. Billotey, A. Le Meur-Herland, T. Brochard, F. Vocanson, M. Janier, P. Perriat, S. Roux, and O. Tillement, " Gadolinium chelate coated gold nanoparticles as contrast agents for both x-ray computed tomography and magnetic resonance imaging.," J. Am. Chem. Soc. JACSAT 0002-7863 130, 5908-5915 (2008). 10.1021/ja078176p (Pubitemid 351620836)
40. J. F. Hainfeld, F. A. Dilmanian, D. N. Slatkin, and H. M. Smilowitz, " Radiotherapy enhancement with gold nanoparticles.," J. Pharm. Pharmacol. JPPMAB 0373-1022 60, 977-985 (2008). 10.1211/jpp.60.8.0005
41. A. Drevelegas, Imaging of Brain Tumors with Histological Correlations (Springer-Verlag, Berlin, 2002).
42. N. J. Patronas, in Imaging of Brain Tumors with Histological Correlations, edited by, A. Drevelegas, (Springer-Verlag, Berlin, 2002), pp. 253-276.
43. S. Corde, A. Joubert, J. F. Adam, A. M. Charvet, J. F. Le Bas, F. Esteve, H. Elleaume, and J. Balosso, " Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds.," Br. J. Cancer BJCAAI 0007-0920 91, 544-551 (2004). 10.1038/sj.bjc.6601951 (Pubitemid 39093577)
44. S. Manolopoulos, C. Wojnecki, S. Green, R. P. Hugtenburg, and B. Jones, " Treatment planning for a synchrotron-based radiotherapy modality.," Appl. Radiat. Isot. ARISEF 0969-8043 67, 492-494 (2009). 10.1016/j.apradiso. 2008.08.005
45. J. L. Robar, S. A. Riccio, and M. A. Martin, " Tumour dose enhancement using modified megavoltage photon beams and contrast media.," Phys. Med. Biol. PHMBA7 0031-9155 47, 2433-2449 (2002). 10.1088/0031-9155/47/14/ 305 (Pubitemid 34823321)
46. K. Pasciuti, G. Iaccarino, A. Soriani, V. Bruzzaniti, S. Marzi, S. Gomellini, S. Arcangeli, M. Benassi, and V. Landoni, " DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans.," Radiother. Oncol. RAONDT 0167-8140 87, 110-115 (2008). 10.1016/j.radonc.2007.12.019
47. M. Renier, T. Brochard, C. Nemoz, H. Requardt, E. Brauer, F. Esteve, J. Balosso, P. Suortti, J. Baruchel, H. Elleaume, G. Berruyer, P. Berkvens, and A. Bravin, " The radiotherapy clinical trials projects at the ESRF: Technical aspects.," Eur. J. Radiol. EJRADR 0720-048X 68, S147-S150 (2008). 10.1016/j.ejrad.2008.04.057